この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2009/9/141 分で読めます
Draft Guidance for Industry and Food and Drug Administration Staff; Clinical Study Designs for Surgical Ablation Devices for Treatment of Atrial Fibrillation; Availability
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing the availability of the draft guidance entitled "Clinical Study Designs for Surgical Ablation Devices for Treatment of Atrial Fibrillation." This draft guidance provides FDA's proposed recommendations on clinical trial designs for surgical ablation devices intended for the treatment of atrial fibrillation. This draft guidance is not final nor is it in effect at this time.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →